Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
445 |
|
| Actual shortage: | 46 (10%) | |
| Anticipated shortage: | 15 (3%) | |
| Avoided shortage: | 8 (2%) | |
| Resolved: | 376 (84%) | |
Discontinuation Reports |
68 |
|
| To be discontinued: | 7 (10%) | |
| Discontinued: | 51 (75%) | |
| Reversed: | 10 (15%) | |
Late reports |
44 (9%) |
|
Overdue reports |
12 (18%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| QUETIAPINE FUMARATE XR | 50MG | TABLET (EXTENDED-RELEASE) | Anticipated shortage | 2024-03-26 | 2024-05-08 | 223344 |
| OLMESARTAN/HCTZ | 40MG 25MG | TABLET | Anticipated shortage | 2024-03-26 | 2024-05-08 | 223370 |
| QUETIAPINE FUMARATE XR | 400MG | TABLET (EXTENDED-RELEASE) | Anticipated shortage | 2024-03-26 | 2024-05-08 | 223373 |
| LETROZOLE | 2.5MG | TABLET | Anticipated shortage | 2024-03-26 | 2024-05-08 | 223376 |
| OLMESARTAN/HCTZ | 40MG 12.5MG | TABLET | Anticipated shortage | 2024-03-26 | 2024-05-08 | 223383 |
| QUETIAPINE FUMARATE XR | 200MG | TABLET (EXTENDED-RELEASE) | Anticipated shortage | 2024-03-26 | 2024-05-08 | 223380 |
| QUETIAPINE FUMARATE XR | 300MG | TABLET (EXTENDED-RELEASE) | Anticipated shortage | 2024-03-26 | 2024-05-08 | 223365 |
| OLMESARTAN/HCTZ | 20MG 12.5MG | TABLET | Anticipated shortage | 2024-03-26 | 2024-05-08 | 223386 |
| OMEPRAZOLE MAGNESIUM DELAYED RELEASE TABLETS | 20MG | TABLET (DELAYED-RELEASE) | Anticipated shortage | 2024-03-26 | 2024-05-08 | 223352 |
| CAPECITABINE | 500MG | TABLET | Anticipated shortage | 2024-03-26 | 2024-05-08 | 223361 |
| CAPECITABINE | 150MG | TABLET | Anticipated shortage | 2024-03-26 | 2024-05-08 | 223358 |
| VARDENAFIL | 10MG | TABLET | Actual shortage | 2024-03-19 | 2024-05-13 | 222747 |
| GABAPENTIN | 400MG | CAPSULE | Actual shortage | 2024-03-25 | 2024-05-16 | 223259 |
| ALFUZOSIN | 10MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-03-27 | 2024-05-17 | 223485 |
| FLUOXETINE | 20MG | CAPSULE | Resolved | 2022-07-12 | 2024-05-17 | 164466 |
| SERTRALINE | 25MG | CAPSULE | Resolved | 2024-01-17 | 2024-05-17 | 216264 |
| SERTRALINE | 50MG | CAPSULE | Resolved | 2024-01-30 | 2024-05-17 | 217783 |
| SERTRALINE | 100MG | CAPSULE | Resolved | 2024-01-17 | 2024-05-17 | 216254 |
| RISPERIDONE | 0.25MG | TABLET | Resolved | 2024-03-25 | 2024-05-17 | 223270 |
| VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2024-04-22 | 2024-05-17 | 225878 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| BUPROPION SR | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151302 |
| BUPROPION SR | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151307 |
| LORAZEPAM | 2.0MG | TABLET | Discontinued | 2021-08-12 | 2022-02-06 | 144029 |
| ALPRAZOLAM | 0.25MG | TABLET | Discontinued | 2021-08-12 | 2022-02-06 | 144035 |
| SOLIFENACIN | 5MG | TABLET | Discontinued | 2023-09-26 | 2023-09-26 | 205215 |
| DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | To be discontinued | 2024-02-15 | 2024-02-15 | 219591 |
| RISEDRONATE | 35MG | TABLET | Discontinued | 2024-02-28 | 2024-02-29 | 220861 |
| DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Reversed | 2024-02-15 | 2024-04-23 | 219618 |